Sono-Tek Receives Hold Rating from Northland Securities' Ted Jackson
ByAinvest
Wednesday, Jun 25, 2025 5:21 am ET1min read
SOTK--
Sono-Tek Corporation (SOTK) has received a significant $1.12 million order from a long-standing client in the medical diagnostic testing industry. This substantial order represents a major evolution in the company's relationship with the client, which has been utilizing Sono-Tek's ultrasonic coating systems for nearly a decade. The order includes a system designed for advanced automation and high-volume product handling, reflecting Sono-Tek's enhanced capabilities [1].
The new system is engineered to support sophisticated automation and reduced operator intervention, enabling scalable production of advanced diagnostic consumables. Delivery and installation are scheduled at the customer’s U.S. facility within the next year. This order aligns with Sono-Tek’s ongoing strategy to deliver fully integrated, high-performance coating platforms that support the scalability and automation demands of high-volume manufacturing in innovation-driven industries such as medical devices, alternative energy, and microelectronics [1].
Sono-Tek, founded in 1975, has evolved from delivering precision coating solutions to R&D and laboratory markets to becoming a global leader in providing scalable, high-performance manufacturing platforms. Today, Sono-Tek’s systems enable thin-film deposition with exceptional uniformity, material efficiency, and process control for advanced applications in medical devices, micro-electronics, alternative energy, and industrial production [1].
The order comes at a time when Sono-Tek reported stable financial performance in its second quarter. The company achieved an earnings per share of $0.02 and revenue of $5.12 million, showcasing stable performance despite market challenges [3]. The company maintains a strong cash position with $11.9 million in cash and equivalents and no debt, supporting its growth initiatives [3].
Northland Securities analyst Ted Jackson maintained a Hold rating on Sono-Tek, citing the company's recent order as a positive development. Jackson has a 4-star rating with an average return of 7.2% and a 51.55% success rate. The analyst consensus remains Hold [2].
References:
[1] https://www.globenewswire.com/news-release/2025/06/23/3103240/0/en/Sono-Tek-Receives-1-12-Million-Order-from-Global-Medical-Diagnostics-Company-for-High-Volume-Coating-Platform.html
[2] https://www.gurufocus.com/news/2940046/sonotek-sotk-secures-significant-112m-order-in-medical-diagnostics-sotk-stock-news
[3] https://www.investing.com/news/company-news/sonotek-receives-112-million-order-from-medical-diagnostics-client-93CH-4105507
Northland Securities analyst Ted Jackson maintained a Hold rating on Sono-Tek (SOTK). The company reported a quarterly revenue of $5.19 million and a net profit of $274.18 thousand. Jackson has a 4-star rating with an average return of 7.2% and a 51.55% success rate. Sono-Tek has an analyst consensus of Hold.
Title: Sono-Tek Secures $1.12 Million Order from Global Medical Diagnostics CompanySono-Tek Corporation (SOTK) has received a significant $1.12 million order from a long-standing client in the medical diagnostic testing industry. This substantial order represents a major evolution in the company's relationship with the client, which has been utilizing Sono-Tek's ultrasonic coating systems for nearly a decade. The order includes a system designed for advanced automation and high-volume product handling, reflecting Sono-Tek's enhanced capabilities [1].
The new system is engineered to support sophisticated automation and reduced operator intervention, enabling scalable production of advanced diagnostic consumables. Delivery and installation are scheduled at the customer’s U.S. facility within the next year. This order aligns with Sono-Tek’s ongoing strategy to deliver fully integrated, high-performance coating platforms that support the scalability and automation demands of high-volume manufacturing in innovation-driven industries such as medical devices, alternative energy, and microelectronics [1].
Sono-Tek, founded in 1975, has evolved from delivering precision coating solutions to R&D and laboratory markets to becoming a global leader in providing scalable, high-performance manufacturing platforms. Today, Sono-Tek’s systems enable thin-film deposition with exceptional uniformity, material efficiency, and process control for advanced applications in medical devices, micro-electronics, alternative energy, and industrial production [1].
The order comes at a time when Sono-Tek reported stable financial performance in its second quarter. The company achieved an earnings per share of $0.02 and revenue of $5.12 million, showcasing stable performance despite market challenges [3]. The company maintains a strong cash position with $11.9 million in cash and equivalents and no debt, supporting its growth initiatives [3].
Northland Securities analyst Ted Jackson maintained a Hold rating on Sono-Tek, citing the company's recent order as a positive development. Jackson has a 4-star rating with an average return of 7.2% and a 51.55% success rate. The analyst consensus remains Hold [2].
References:
[1] https://www.globenewswire.com/news-release/2025/06/23/3103240/0/en/Sono-Tek-Receives-1-12-Million-Order-from-Global-Medical-Diagnostics-Company-for-High-Volume-Coating-Platform.html
[2] https://www.gurufocus.com/news/2940046/sonotek-sotk-secures-significant-112m-order-in-medical-diagnostics-sotk-stock-news
[3] https://www.investing.com/news/company-news/sonotek-receives-112-million-order-from-medical-diagnostics-client-93CH-4105507

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet